New radioactive therapy targets Hard-to-Treat breast cancer
Disease control
Recruiting now
This early-stage trial tests a new radioactive drug called [177Lu]Lu-ABY-271 in people with HER2-positive metastatic breast cancer that has spread and cannot be removed by surgery. The main goals are to check safety and see where the drug travels in the body. About 21 participant…
Phase: PHASE1 • Sponsor: Affibody • Aim: Disease control
Last updated May 22, 2026 14:01 UTC